Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 9, 2006, Pages 3113-3118

  Sriram, Dharmarajan ^a   Yogeeswari, Perumal ^a   Devakaram, Ruth Vandana ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Acid hydrazones; Amides; Anti TB; Antimycobacterial; Diclofenac derivatives

Indexed keywords

1 CYCLOPROPYL 6 FLUORO 8 METHOXY 7 [[N 4 (2 (2 (2,6 DICHLOROPHENYLAMINO)PHENYL)ACETYL) 3 METHYL] N 1 PIPERAZINYL] 4 OXO 1,4 DIHYDRO 3 QUINOLINE CARBOXYLIC ACID; AMIDE; ANTIMYCOBACTERIAL AGENT; CARBOXYLIC ACID DERIVATIVE; CIPROFLOXACIN; DICLOFENAC; HYDRAZONE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS;

AMIDES; ANIMALS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; DICLOFENAC; HYDRAZONES; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 33644982058     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.12.042     Document Type: Article

References (14)

1. WHO Web site, and NIAID Web site, .
2. D.E. Snider, and K.G. Castro N. Eng. J. Med. 338 1998 1689
3. G. Sbardella, A. Mai, M. Artico, R. Loddo, M.G. Setzu, and P. La Colla Bioorg. Med. Chem. Lett. 14 2004 1537
4. Y. Zhang, and L.M. Amzel Curr. Drug. Targets 3 2002 131
5. C. Crabb Bull. World Health Organ. 80 2002 517
6. N.K. Dutta, K.A. Kumar, K. Mazumdar, and S.G. Dastidar Indian J. Exp. Biol. 42 2004 922
7. S.E. Abbas, H.E. Abou-Youssef, and K.L. Matta Egypt. J. Pharm. Sci. 32 1991 515
8. S.G. Komurcu, S. Rollas, M. Ulgen, and J.W. Gorrod Boll. Chim. Farmac. 134 1995 375
9. National Committee for Clinical Laboratory Standards. Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Proposed standard M24-T. National Committee for Clinical Laboratory Standards, Villanova, PA, 1995.
10. K. Novak, B. Noszal, I. Hermecz, G. Kereszturi, B. Podanyi, and G. Szasz J. Pharm. Sci. 79 1990 1023
11. D.B. Young Strategies for new drug development B.R. Bloom Tuberculosis 1994 ASM Press Washington, DC 559 567
12. L.L. Gundersen, J. Nissen-Meyer, and B. Spilsberg J. Med. Chem. 45 2002 1383
13. D. Sriram, P. Yogeeswari, S.J. Basha, D.R. Radha, and V. Nagaraja Bioorg. Med. Chem. 13 2005 5774
14. R.E. Kirk Experimental design procedures for the behavioral sciences 1986 Brooks-Cole Belmont, Calif